tiprankstipranks
Uipath Inc (PATH)
NYSE:PATH
Want to see PATH full AI Analyst Report?

UiPath (PATH) AI Stock Analysis

8,015 Followers

Top Page

PATH

UiPath

(NYSE:PATH)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
$12.00
▲(15.27% Upside)
Action:Reiterated
Date:06/30/26
PATH scores well primarily on improving fundamentals—strong cash flow conversion, a low-leverage balance sheet, and a clear shift to profitability. The earnings call reinforces this with upbeat FY27 guidance and AI-driven enterprise deal momentum, partially offset by modest net new ARR and small-customer churn. The main drag on the overall score is technical weakness (below key moving averages with negative MACD), while valuation appears fair with a mid-teens P/E and no dividend support.
Positive Factors
Free Cash Flow Strength
UiPath's consistent TTM free cash flow near $375M and nearly one-to-one conversion with net income indicates durable cash generation. This provides long-term flexibility to fund product R&D, strategic partnerships, buybacks, and weather demand cycles without relying on external financing.
Negative Factors
Modest Net New ARR
Net new ARR of only $49M against a $1.901B base highlights slower incremental customer-base expansion. Over time, modest new ARR can limit top-line growth even with strong retention, making sustained revenue expansion dependent on larger expansions or higher deal velocity.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Strength
UiPath's consistent TTM free cash flow near $375M and nearly one-to-one conversion with net income indicates durable cash generation. This provides long-term flexibility to fund product R&D, strategic partnerships, buybacks, and weather demand cycles without relying on external financing.
Read all positive factors

UiPath Key Performance Indicators (KPIs)

Any
Any
Dollar-Based Net Retention Rate
Dollar-Based Net Retention Rate
Tracks how revenue from existing customers changes over time after accounting for expansions, contractions, and churn; a rate above 100% means upsells and cross-sells more than offset losses and indicates healthy land‑and‑expand economics. For UiPath, a high net retention rate suggests sticky automation deployments and predictable growth from the installed base, while a declining rate warns of weakening adoption or pricing pressure.
Chart InsightsRetention has trended down since 2021, reflecting weaker expansion and churn concentrated in the smallest customers; that structural erosion helps explain modest net‑new ARR despite revenue beats. The recent uptick aligns with management’s notes that AI-led upsells are driving much larger enterprise expansions, but overall retention remains well below its historic peak—meaning UiPath will need continued success in big-ticket AI deals, improved small‑customer retention, or more consumption monetization to sustainably accelerate organic ARR growth.
Data provided by:The Fly

UiPath (PATH) vs. SPDR S&P 500 ETF (SPY)

UiPath Business Overview & Revenue Model

Company Description
UiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company's integrated software suite empowers organizat...
How the Company Makes Money
UiPath primarily makes money by selling subscriptions to its automation software platform, typically on multi-period contracts with enterprises and public-sector customers. The main revenue stream is recurring subscription revenue from licenses fo...

UiPath Earnings Call Summary

Earnings Call Date:May 28, 2026
(Q1-2027)
|
% Change Since: |
Next Earnings Date:Sep 08, 2026
Earnings Call Sentiment Positive
The call presented strong execution: revenue acceleration, the company’s first GAAP profitable quarter, meaningful non-GAAP margins and free cash flow, healthy cash reserves and active buybacks, and clear momentum in AI and product launches driving large enterprise deals. Key concerns were modest net new ARR relative to the ARR base, churn concentrated in the smallest customers, and expected FX headwinds. Management framed ARR/revenue timing differences as accounting and mix effects and emphasized continued investment in AI, orchestration, and go-to-market execution. Overall, the positive operating and financial progress, coupled with strong AI-driven deal traction and improved profitability, outweigh the highlighted challenges.
Positive Updates
Revenue Growth and Strong Quarter
Reported revenue of $418 million, up 17% year-over-year (15% growth when normalizing for a $7 million FX tailwind). Management noted the quarter beat guidance across key financial metrics.
Negative Updates
Modest Net New ARR Relative to Base
Net new ARR was $49 million, which is modest relative to a $1.901 billion ARR base and may signal slower incremental ARR expansion in the near term.
Read all updates
Q1-2027 Updates
Negative
Revenue Growth and Strong Quarter
Reported revenue of $418 million, up 17% year-over-year (15% growth when normalizing for a $7 million FX tailwind). Management noted the quarter beat guidance across key financial metrics.
Read all positive updates
Company Guidance
UiPath guided Q2 FY27 revenue of $395–$400 million, ARR of $1.929–$1.934 billion, non‑GAAP operating income of approximately $75 million and a basic share count of ~518 million; for full‑year FY27 it expects revenue of $1.776–$1.781 billion, ARR of $2.058–$2.063 billion, non‑GAAP operating income of about $430 million, non‑GAAP adjusted free cash flow of roughly $425 million and non‑GAAP gross margin of ~84%, while noting a nominal incremental FX headwind to ARR and revenue.

UiPath Financial Statement Overview

Summary
Financials show a meaningful turnaround with strong TTM profitability (net margin ~19.6%, positive EBIT), very high gross margin (~83%), and robust cash generation (TTM FCF ~$375M; ~0.98x net income). Balance sheet is a key strength with minimal leverage (debt-to-equity ~3–4%) and improved ROE (~17.3%). The main offset is decelerating revenue growth in TTM (~3.8%), so sustained profitable growth still needs to be proven.
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
84
Very Positive
BreakdownTTMJan 2026Jan 2025Jan 2024Jan 2023Jan 2022
Income Statement
Total Revenue1.67B1.61B1.43B1.31B1.06B892.25M
Gross Profit1.39B1.34B1.18B1.11B878.53M723.38M
EBITDA160.16M117.60M-60.87M-53.22M-298.84M-496.18M
Net Income327.41M282.33M-73.69M-89.88M-328.35M-525.59M
Balance Sheet
Total Assets2.90B3.18B2.87B2.95B2.74B2.57B
Cash, Cash Equivalents and Short-Term Investments1.31B1.47B1.63B1.88B1.76B1.87B
Total Debt83.00M81.25M77.82M67.07M63.44M51.40M
Total Liabilities1.00B1.10B1.02B938.64M815.05M650.53M
Stockholders Equity1.90B2.08B1.85B2.02B1.92B1.92B
Cash Flow
Free Cash Flow375.23M352.16M305.64M291.74M-33.80M-68.02M
Operating Cash Flow384.13M371.21M320.56M299.08M-9.98M-54.96M
Investing Cash Flow-55.38M-22.47M-45.50M-439.57M-289.14M-35.44M
Financing Cash Flow-389.36M-372.38M-450.51M-196.90M-60.67M1.47B

UiPath Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.41
Price Trends
50DMA
10.76
Positive
100DMA
10.94
Positive
200DMA
12.97
Negative
Market Momentum
MACD
0.05
Negative
RSI
62.34
Neutral
STOCH
85.73
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PATH, the sentiment is Positive. The current price of 10.41 is below the 20-day moving average (MA) of 10.72, below the 50-day MA of 10.76, and below the 200-day MA of 12.97, indicating a neutral trend. The MACD of 0.05 indicates Negative momentum. The RSI at 62.34 is Neutral, neither overbought nor oversold. The STOCH value of 85.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PATH.

UiPath Risk Analysis

UiPath disclosed 1 risk factors in its most recent earnings report. UiPath reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

UiPath Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$5.32B16.4217.29%15.24%
76
Outperform
$28.54B-987.15-0.99%23.64%68.36%
69
Neutral
$5.58B27.3013.99%7.06%-22.01%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
$5.15B-21.49%21.38%27.92%
56
Neutral
$4.92B-37.93-26.10%15.27%-39.93%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PATH
UiPath
11.71
-1.45
-11.02%
ACIW
ACI Worldwide
54.88
9.41
20.69%
VRNS
Varonis Systems
42.86
-8.24
-16.13%
MDB
MongoDB
354.88
144.87
68.98%
S
SentinelOne
17.51
-0.69
-3.79%

UiPath Corporate Events

Executive/Board ChangesShareholder Meetings
UiPath Shareholders Back Board, Pay and Auditor Decisions
Positive
Jun 29, 2026
At its June 25, 2026 annual meeting, UiPath reported that holders of approximately 93.78% of the voting power of its Class A and Class B shares were represented, constituting a quorum. Shareholders elected seven directors to serve on the board unt...
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
UiPath Delivers Strong Q1 Results and First GAAP Profit
Positive
May 28, 2026
UiPath reported first quarter fiscal 2027 results on May 28, 2026, with revenue rising 17% year-on-year to $418 million and annualized recurring revenue reaching $1.901 billion, up 12% from a year earlier as of April 30, 2026. The company delivere...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 30, 2026